RecruitingNCT06320483

Evaluation of the Effectiveness and Safety of Vibro-acoustic Pulmonary Therapy (VAPT) in Complex Therapy for Acute Respiratory Failure of Mixed Type I-II Stages in Comparison With Percussion Massage in Cardiac Surgical Patients in the Early Postoperative Period


Sponsor

Bark Technology LLP

Enrollment

310 participants

Start Date

Sep 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to evaluate the effectiveness and safety of vibro-acoustic pulmonary therapy (VAPT) in complex therapy for the acute respiratory failure of mixed type I-II stages in comparison with percussion massage in cardiac surgical patients in the early postoperative period.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study compares two chest physiotherapy techniques — vibro-acoustic pulmonary therapy (VAPT) versus traditional percussion massage — for clearing mucus from the lungs in patients who develop breathing problems after open-heart surgery. **You may be eligible if...** - You are between 18 and 80 years old - Your BMI is between 18.5 and 35 - You underwent planned cardiac (heart) surgery under general anesthesia using a heart-lung machine (lasting more than 3 hours) - You developed a moderate breathing problem after surgery (oxygen levels below 95% while breathing normal air) - Your heart's pumping function before surgery was above 40% - Your vital signs are stable after surgery **You may NOT be eligible if...** - Your breathing problem was severe before or during surgery - You have had a recent heart attack or severe bleeding - You required emergency surgery or have other serious post-operative complications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVibroacoustic device BARK VibroLUNG

The BARK VibroLUNG vibroacoustic device is intended for the treatment and prevention of respiratory pathologies. The BARK VibroLUNG vibroacoustic device with accessories is a medical device and is intended for the treatment of pathological conditions associated with obstructive and restrictive lung diseases in patients in medical institutions. Field of application: physiotherapy of the chest organs, treatment and prevention of respiratory failure. The therapeutic mechanism of action is due to three main effects: improved bronchial drainage, improved ventilation-perfusion ratios, and the "lung opening" maneuver.


Locations(5)

JSC "National Research Cardiac Surgery Center"

Astana, Kazakhstan

State-owned public enterprise with the right of economic management "Atyrau Regional Cardiology Center"

Atyrau, Kazakhstan

State-owned public enterprise with the right of economic management "Regional Cardiology Center"

Oral, Kazakhstan

State-owned public enterprise with the right of economic management "Pavlodar Regional Cardiology Center"

Pavlodar, Kazakhstan

State-owned public enterprise with the right of economic management "East Kazakhstan Regional Hospital"

Ust-Kamenogorsk, Kazakhstan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06320483